Ancora Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Ancora Advisors’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-73,212	Closed	-$217K	–	1277
2016 Q3	$217K	Sell	73,212 -3,277	-4%	-$5.68K	0.02%	465
2016 Q2	$114K	Buy	+76,489	New	+$175K	0.01%	492

Ancora Advisors's AEGR Position: Q4 2016 in Review

Ancora Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 73,212 shares — an estimated $217K sold.

Ancora Advisors first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $217K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Ancora Advisors reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Ancora Advisors sold 73,212 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $217K.
Ancora Advisors first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
Ancora Advisors's Aegerion Pharmaceuticals position peaked at $217K in Q3 2016.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Ancora Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.